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Background: There is as yet no evidence on the feasibility of implementing recommendations from the National
Institute of Health and Care Excellence (NICE) osteoarthritis (OA) guidelines in primary care, or of the effect these
recommendations have on the condition. The primary aim of this study is to determine the clinical and cost
effectiveness of a model OA consultation (MOAC), implementing the core recommendations from the NICE OA
guidelines in primary care. Secondary aims are to investigate the impact, feasibility and acceptability of the MOAC
intervention; to develop and evaluate a training package for management of OA by general practitioners (GPs) and
practice nurses; test the feasibility of deriving ‘quality markers’ of OA management using a new consultation
template and medical record review; and describe the uptake of core NICE OA recommendations in participants
aged 45 years and over with joint pain.
Design: A mixed methods study with a nested cluster randomised controlled trial.
Method: This study was developed according to a defined theoretical framework (the Whole System Informing
Self-management Engagement). An overarching model (the Normalisation Process Theory) will be employed to
undertake a comprehensive ‘whole-system’ evaluation of the processes and outcomes of implementing the MOAC
intervention. The primary outcome is general physical health (Short Form-12 Physical component score [PCS])
(Ware 1996). The impact, acceptability and feasibility of the MOAC intervention at practice level will be assessed by
comparing intervention and control practices using a Quality Indicators template and medical record review. Impact
and acceptability of the intervention for patients will be assessed via self-completed outcome measures and
semi-structured interviews. The impact, acceptability and feasibility of the MOAC intervention and training for GPs
and practice nurses will be evaluated using a variety of methods including questionnaires, semi-structured
interviews, and observations.
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Discussion: The main output from the study will be to determine whether the MOAC intervention is clinically and
cost effective. Additional outputs will be the development of the MOAC for patients consulting with joint pain in
primary care, training and educational materials, and resources for patients and professionals regarding supported
self-management and uptake of NICE guidance.
Trial registration: ISRCTN number: ISRCTN06984617.
Keywords: Osteoarthritis, General practice, Implementation, Primary care, NICE guidelines, Self-managementBackground
There is a perception that osteoarthritis (OA) is a ‘natural’
part of ageing and there are limited interventions available
[1,2]. Whilst there are many published guidelines on the
treatment of OA [3-10] there is a gap between the care that
is recommended and the care that patients receive [11,12].
NICE have recommended that all patients with OA should
be offered three core treatments when they first present in
primary care (see Figure 1): education and access to infor-
mation; advice on local muscle strengthening exercise and
general aerobic fitness; and, if appropriate, advice on losing
weight [13].
For patients and healthcare professionals (HCPs) in pri-
mary care, the clear message that emerges from the guide-
lines is that there is a range of simple interventions for
which there is evidence of clinical effectiveness. By contrast,
there is clear evidence that the core aspects of assessment
and management of OA as currently delivered in primary
care do not meet the recommendations of these guidelines
[11]. Two recent Delphi consensus exercises have been
conducted to address the limited research evidence on the
content of a model OA consultation during which the core
package of care could be delivered [14,15]. However, thereFigure 1 National Institute for Health and Clinical Excellence (NICE) o
Reproduced from, Care and management of osteoarthritis in adults: summ
2008, with permission from BMJ Publishing Group Ltd.is as yet no evidence on the feasibility of using this model
consultation as a way of implementing NICE core OA treat-
ments in primary care and the effect of this support for self-
management on the course and impact of the condition.
The importance of self-management for long term ill-
nesses and of professional support for self-management are
emphasised in NHS policy [16]. Studies have shown that
among patients consulting for knee OA, core treatments
were mostly self- rather than doctor-initiated [1,11]. Previ-
ous research suggests that patients need more information
about OA to enable them to manage their condition more
effectively [17]. Lay ideas of self-management include
minimising the impact of conditions [18,19], maintain-
ing a sense of ‘normality’ [18,20], and maintaining so-
cial roles and obligations [21,22].
The way in which complex interventions, such as
supported self-management approaches, are developed
and then become embedded in routine clinical practice
needs to be supported by theoretical models and evalu-
ated appropriately [23]. A specific model of support for
self-management called the ‘Whole system Informing
Self-management Engagement’ (WISE) model [24] is predi-
cated upon the argument that for self-management supportsteoarthritis treatment recommendations (Conaghan et al. [10]).
ary of NICE guidance, Conaghan P, Dickson J, Grant R, 336, 502-503,
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ation of the patient agenda into the consultation, including
what they are already doing. A whole systems approach
is needed, which engages with practitioners and service
organisations as well as the patient [24]. The WISE model
has been used in a number of long-term illnesses [25-27],
and envisages informed patients receiving support and
guidance from trained practitioners who are working
within a healthcare system that is geared up to be respon-
sive to patients’ needs.
Michie and colleagues have produced a synthesis of
psychological theories to enable design and imple-
mentation of behaviour change interventions [28-30],
and Grol and colleagues have developed a useful
framework for translating evidence into practice [31].
The Calgary-Cambridge framework has specifically
been developed to enhance consultation skills [32].
The Normalisation Process Theory (NPT) [33,34] is a
sociological theory concerned with understanding and
evaluating how complex interventions become em-
bedded in routine clinical practice. These approaches
will be integrated to develop the model OA consul-
tation (MOAC) intervention and the HCP training in
this study.
This study is focused on determining the current
management of OA in consultations and whether sup-
ported self-management, delivered in a model OA con-
sultation, could offer a clinically practicable approach
to implementing the core NICE recommendations. We
will undertake a cluster randomised controlled trial
(RCT) to evaluate the whole systems approach and to
determine the clinical and cost effectiveness of the MOAC
intervention. The protocol has been reported using the
SPIRIT recommendations [35,36].
Aims
The primary aim of the study is to:
1. Determine the clinical and cost effectiveness of the
MOAC intervention in patients with OA.
Secondary aims are to:
1. Describe the uptake of core NICE OA
recommendations in participants aged 45 years
and over with joint pain;
2. Test the feasibility of deriving ‘quality markers’ of
OA management using a new consultation template
and medical record review;
3. Develop and evaluate a training package for
management of OA by general practitioners (GPs)
and practice nurses;
4. Investigate the impact, feasibility and acceptability of
the MOAC intervention.Design
The MOSAICS study is a mixed methods study with a
nested cluster RCT based in eight general practices,
comprising of four components (see Figure 2).
Participants
HCPs and their respective practice populations from
eight general practices will be invited to participate
and randomly allocated to two clusters: ‘intervention’
and ‘control’ practices. The practice populations of the
practices recruited, aged 45 years and over, will form the
sampling frame for the overall study. The eligibility cri-
teria for the study are described in Table 1. Resources
to support primary care engagement are described in
Additional file 1.
Ethics approval
The study has been approved by the North West 1
Research Ethics Committee, Cheshire (REC reference:
10/H1017/76).
Consent
Informed consent will be obtained from all HCPs
and patients participating in the study (see Additional
file 2).
Components of the MOSAICS study
1. The cluster randomised controlled trial
2. Population survey
3. Consultation template and medical record review
4. Evaluation of the MOAC intervention and the training
Study component 1: The cluster RCT
This will be a two-arm prospective pragmatic cluster RCT
based in eight general practices in the North West mid-
lands and Cheshire, UK. This trial will test the hypothesis
that the MOAC intervention is superior to control and will
be a parallel group longitudinal design with repeated mea-
sures. Practices will be randomly allocated to two clusters:
‘intervention’ and ‘control’ practices. Stratified block ran-
domisation will be performed with the practices stratified
into four largest and four smallest practices by list size. In
each stratum, the practices will be randomly allocated by a
computerised random number generator using blocking
with two practices per study group.
Recruitment to the trial will occur over a six-month
period. All practices will use the OA template and will be
given standard information on OA for patients and health-
care professionals published by Arthritis Research UK. In
four practices, patients will receive the MOAC intervention,
while the other four practices will continue to provide usual
care. GPs in the intervention arm will be offered training
for the initial consultation (MOAC 1), and practice nurses
Figure 2 MOSAICS study overview.
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tations (MOAC 2), to deliver supported self-management
of OA. The control practices will have the opportunity to
receive the training at the end of data collection.
The intervention
The MOAC intervention
In order to identify the content of the MOAC interven-
tion, two consensus exercises with GPs, lay participants,
practice nurses, community pharmacists, and allied health
professionals (occupational therapists, physiotherapists,
podiatrists) have been conducted [14,15]. Using the find-
ings of these exercises and theoretical models to guide
self-management (WISE) and support patient behaviour
change, a three-stage consultation has been proposed. The
MOAC intervention comprises of MOAC 1 (initial con-
sultation with GP), MOAC 2 (follow-up visits with prac-
tice nurse) [37], and MOAC 3 (dissemination to other
HCPs). Consultations will be recorded in the general
practices through the use of the joint pain and OAconsultation template (Additional file 3 provides the
full details of the intervention).
The OA Guidebook
The Arthritis Research UK Primary Care Centre at Keele
University has developed a guidebook for patients and
professionals to use as an aid to support self-management
for OA, and this will be used in MOAC [38]. The OA
Guidebook contains both evidence-based biomedical
information and lay experiential knowledge about the
nature of OA, how it is diagnosed and treated, and the
ways in which people who have OA continue to keep
going in their everyday lives. Together these will give
patients insight into the rationale for the advice and
treatments offered in MOAC 1, 2 and 3 and what,
practically, people who have OA have found helpful in
learning to live with the condition. The patient guide-
book will be a useful way to reinforce verbal informa-
tion given by HCPs, to act as a resource to consult
if queries or uncertainties arise in the future, to help




• Member of the Central England PCRN or
a Keele Research Network Practice
• At least two GPs willing to undertake the
study as per protocol, i.e., act as a control
or intervention practice
• Willing, and able, to allow one (or for
preference two – to allow for cross cover)
of their practice nurses to be trained to
deliver the MOAC 2 clinics
• Able to physically accommodate the
nurse clinics in the practice
• Uses the EMIS computerised
consultation system
• Nurses and GPs consenting to follow
up by the MOSAICS study team
• GPs willing to be trained to carry out
the MOAC 1 consultations
• Nurses willing to be trained to carry
out the MOAC 2 clinics
• Nurses who consent to being observed
and audio recorded in MOAC 2 clinics
*Patients Inclusion Criteria:
• Males and Females
• 45 years and over
• Registered with a MOSAICS study practice
• Consenting to further contact from the
study team and medical record review
(consent sought as part of the Patient
Population Survey)
Exclusion Criteria:
• Excluded via GP screen of practice list
• Unable to give fully informed consent,
e.g., learning difficulties or dementia
• Resident in a care or nursing home
• History of serious disease, e.g.,
malignancy, terminal illness
• Unable to consult in the general
practice
• Flagged as excluded from research in
that practice
EMIS = Egton Medical Information System; GP = General Practitioners;
MOAC = Model Osteoarthritis Consultation; MOSAICS = Management of
Osteoarthritis In consultations; OA = Osteoarthritis; PCRN = Primary Care
Research Network.
*All patients registered with MOSAICS practices randomised to the
intervention arm of the study had access to the MOAC 1 and MOAC 2 clinics,
including those who did not consent to be followed up, as these ran as part
of normal clinical care within each intervention practice.
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tions to ask HCPs.
The training
Training and educational packages will be developed for
GPs and practice nurses by drawing on the work ofMichie et al. [29,30]. GPs will receive training on how to
deliver the initial consultation (MOAC 1) for a new or
established patient consulting with OA and the procedure
for referring to a practice nurse for a follow-up OA con-
sultation (MOAC 2). Practice nurses will receive training
in how to support and enable patients to self-manage OA,
using a patient-centred approach, an OA guidebook, goal
setting, pain management and the core NICE recommen-
dations (information and advice, strengthening exercise and
aerobic fitness training, and weight management). Nurses
will also receive training in how to complete the MOAC 2
case report form (CRF), which will be completed for each
patient attending the MOAC 2 consultations. Full details of
these training packages will be published separately.
For MOAC 3, members of the wider multidisciplinary
team linked to the intervention practices (e.g., physiothera-
pists, occupational therapists, podiatrists, pharmacists) will
be invited to workshops to increase awareness of the study
and its aims.
Sample size
Published research in musculoskeletal disorders has
estimated a minimal clinically important difference
(MCID) from 2 to 4 points for the SF-36 version 2 Physical
Component Summary (PCS) subscale [39], which has
a normalised population standard deviation (SD) of 10.
Hence, a difference between groups of 0.3 of an effect size
is considered a minimum clinically important difference
(MCID) threshold for the purposes of demonstrating su-
periority in the MOSAICS RCT.
In total, 500 patients will need to be recruited in ex-
pectation that 400 will provide data at six months. A
total of 400 participants (200 to each arm) will ensure
90% power to detect at least the effect size of 0.3 at the
primary time point of six months follow-up given a 5%
two-tailed significance level. Randomisation is by practice,
so this sample size calculation was inflated to correct for an
intracluster correlation coefficient (adjusted ICC of 0.005),
varying practice size recruitment was taken into account
(including coefficient of variation of 0.5 as per POST trial
[ISRCTN40721988]) and inclusive of (×0.67) and × 1.25




Eligible participants who consented to medical record
review and further contact in the initial baseline pa-
tient population survey (see component 2), and who
subsequently consult with joint pain in one of the four
intervention practices will be identified via fortnightly
electronic searches of consultation data and receive a
consultation questionnaire asking about their consultation
experience with the MOAC intervention. This will also be
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practices, to enable comparison of patient reported clin-
ical outcomes.
The primary clinical outcome measure for the cluster
RCT is the SF12 PCS [40]. The primary follow-up time
point is six months. Key secondary outcomes include
the Arthritis Self-Efficacy pain subscale [41] and the
OMERACT/OARSI responder criteria [42]. Other out-
come measures collected in the trial can be found in
(Table 2). Participants will be followed up at 3, 6
and 12 months after consultation to determine short,
medium and long term behaviours and patterns of the
uptake of core OA treatments. Process outcome mea-
sures will also be collected within the study (e.g.,
achieving Quality Indicators of care).
The trial statistician will be kept blind to the practice
allocation until after the analysis of the primary and
secondary outcomes (blinding will be broken for the
per protocol analysis) [43].
Objectives: Study component 1
1a.To determine the clinical and cost effectiveness of
the MOAC intervention in four general practices
compared with four control practices using patient
reported outcome measures.
1b.To train healthcare professionals (GPs and practice
nurses) to deliver the MOAC intervention.
1c.To implement the MOAC intervention to deliver
supported self-management for adults with OA
within routine primary care.
Trial status
Eight general practices have been recruited, and the
intervention has been developed and delivered in the
four intervention practices. We expect follow-up data
collection to be complete in 2014.
Study component 2: Population survey
A cross sectional population survey will be mailed to
an estimated sample of 30,000 adults aged 45 years and
over registered in the eight participating general practices
participating in the study. After exclusions and based on
previous similar studies from the Research Centre, we an-
ticipate a sample of 9,600 with self-reported joint pain.
The population survey will use a 2-stage mailing process
based on established procedures conducted in the Arthritis
Research UK Primary Care Centre. Eligible participants
will be sent a letter of invitation to take part in the survey,
information about the study, and the population survey.
This survey will collect demographic and work-related data
and ask questions regarding general and psychological
health, physical activity, joint pain in the last 12 months,
consultation behaviour and the management of their jointpain (knee, hip, foot, hand) (the full list of outcome
measures can be found in Table 3). Consent will be
sought for further involvement in the MOSAICS study
and for allowing access to their medical records. Indi-
viduals excluded by the GP or contacting the research
team and not wishing to take part in the study will be
tagged in the practices as exclusions and will not be
contacted again for this study. After two weeks, non-
responders will be sent a reminder survey and letter.
Those that respond to the population survey and agree
further contact will be approached for data collection re-
garding the cluster RCT if they consult with joint pain
during the recruitment period. The key reason for doing
this is to minimise selection bias in the trial by separating
the process of consent from the intervention.
Objectives: Study component 2
2a.To describe pain severity, general health, psychological
status, and uptake of core treatments for OA
recommended by NICE in participants aged 45 years
and over with joint pain (hip, knee, hand, foot).
2b.To identify a population within the practices that
agrees to further contact and medical record review
and can therefore be approached for data collection
for the cluster RCT.
Study component 3: Consultation template and medical
record review
This component will collect anonymised practice-level data
to describe the management of OA in primary care via
retrospective and prospective medical record review in
the eight practices recruited to the study. The OA con-
sultation template will record specific Quality Indicators
for the core management of OA which are not routinely
recorded in practice. These indicators were established
through a systematic review of Quality Indicators of
OA [48]. These include pain and functional impairment,
provision of information, advice about exercise and weight
loss, and advice about pharmacological management
such as use of paracetamol and topical non-steroidal
anti-inflammatory drugs (NSAIDs).
A download of routine consultation, prescription and
other management data related to joint pain and OA
will be obtained for the preceding 12 months before
the introduction of the template. Data regarding cer-
tain co-morbidities, identified as having implications
for prescribing behaviours in the management of joint
pain and OA, will also be obtained for three years pre-
ceding the introduction of the template.
The OA consultation template will then be introduced
in all of the eight practices at baseline (six months
prior to randomisation of the practices for the cluster
RCT described in component 1). Training regarding use of
Table 2 Consultation survey measures
Data Collection Measurement Scale
Time points
Baseline 3 months 6 Months 12 Months
Demographic Information
Age Years ✓ ✓ ✓ ✓
Gender Female/Male ✓ ✓ ✓ ✓
Weight Stones and lbs or Kilograms ✓ ✓ ✓ ✓
Work related Questions
Current/most recent job title Free Text ✓ ✓ ✓ ✓
Currently in a paid Job Yes/No/Retired ✓ ✓ ✓ ✓
Typical working week
Working full time (30 hours or more per
week)/ Working part time (29 hours or
less per week)/
✓ ✓ ✓ ✓
Time off during last 6 months because of
joint pain including time off to visit any
health care professional
Yes/No ✓ ✓ ✓ ✓
How many days, weeks or months were
you absent from work due to joint pains
in the last 6 months
Number of days/weeks/months ✓ ✓ ✓ ✓
Consultations
GPAQ communication sub scale [43] 8 – 56 ✓
GPAQ for Nurses communication sub
scale (modified GPAQ [43])
8 – 56 ✓




Specific Joint Pain and Problems in knee/
hip/hand/foot over 3 months
Yes/No ✓ ✓ ✓ ✓
Pain intensity in the knee/hip/hand/foot
over 3 months
0-10 numerical rating scale ✓ ✓ ✓ ✓
WOMAC Physical function subscale [44] 0 - 32 ✓ ✓ ✓ ✓
AIMS 2 hand and finger function
subscale [45]
0-20 ✓ ✓ ✓ ✓
Physical Activity
IPAQ [46]
Categorical score: low, moderate, high
✓ ✓ ✓ ✓
Continuous score: MET-min per week
Walking Questions
Where do you regularly walk for reasons
including health and well-being?/ Who
do you regularly walk with?
✓ ✓ ✓ ✓
PASE [47] 0 – 361 ✓ ✓ ✓ ✓
Global Assessment of change [48]
Completely recovered, much better,
better, no change, worse, much worse
✓ ✓ ✓
General health and Well being
PHQ8 [49] 0 – 24 ✓ ✓ ✓ ✓
GAD7 [50] 0 – 21 ✓ ✓ ✓ ✓
SF12 version 2 [40] 0 – 100 ✓ ✓ ✓ ✓
SF6D [51] 0.29-1
EQ-5D [52] -0.59-1 ✓ ✓ ✓ ✓
ICECAP-A version 2 [53] 4 - 20 ✓ ✓ ✓ ✓
Managing your joint problems
Arthritis Self Efficacy pain sub scale [41] 0 - 10 ✓ ✓ ✓ ✓
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Table 2 Consultation survey measures (Continued)
Patient generated OA Quality Indicators
(Adapted from Østerås et al [54])
15 questions (Yes/No/Don’t remember) ✓ ✓ ✓ ✓
Medication/Treatment Use (adapted for
joint problems from Jinks et al [55])
Simple count of strategies used ✓ ✓ ✓ ✓
Patient Enablement (modified from
Howie et al [56])
0 - 10 ✓ ✓ ✓
Healthcare Utilisation
Self-help remedies, contact with NHS and




AIMS 2 = Arthritis Impact Measurement Scale; GAD 7= Generalized Anxiety Disorder 7; GP = General Practitioner; GPAQ = General Practice Assessment
Questionnaire;
ICECAP-A = self-report measure of capability wellbeing for adults; IPAQ: International Physical Activity Questionnaire; MET = Metabolic Equivalent; PASE = Physical
Activity Scale for the Elderly; PHQ8 = Patient Health Questionnaire 8; EQ5D = Quality of Life; SF12 = Short Form 12; SF6D = Short Form 6D; WOMAC = Western
Ontario and McMaster Universities Arthritis Index.
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presenting with a working diagnosis of OA (knee, hip, hand
or foot pain) will be provided for the GPs and practice
nurses. When a patient aged 45 or over with joint pain con-
sults in any of the eight practices and the GP or practice
nurse enters a Read code for OA or one of a selection of
joint pain Read codes (see Additional file 4), the OA
consultation template will open to allow data entry. The
GP or practice nurse undertaking the consultation may
complete the template, or bypass the template, as ap-
propriate (for various reasons, such as the joint pain not
being related to OA). Data on routine recording of man-
agement and Quality Indicators will be collected in the
template prospectively at 6 months after baseline and
21 months by downloading anonymised practice data.
Objectives: Study component 3
3a.To describe the current recording patterns and
management of OA in primary care based on a
12-month retrospective download of medical records.
3b.To describe change in the recording patterns and
management of OA in primary care following
(i) activation of the template, and (ii) delivery of the
MOAC intervention, based on prospective
downloads of medical records.
Study component 4: Evaluation of the MOAC intervention
and the training
This component will evaluate (i) the implementation of the
MOAC intervention at the level of the service, HCPs and
patients, and (ii) the training. Both qualitative and quantita-
tive methods will be used.
Evaluation of the intervention
Practice level evaluation
Observations of a number of relevant meetings will be
undertaken. The number of observations will be decided, in
negotiation with each intervention practice. The intentionis to observe all relevant clinical, management and research
meetings to reveal how the intervention is operationalised
within practice. In order to document events, observations
will be structured and will use audio recordings and an ob-
servation framework to capture data for analysis. Secondary
data collection will also be undertaken to determine adher-
ence to the intervention. For example, notes of meetings in
the practices, MOAC 2 CRFs, patient records, and patient
feedback forms will be used to gain an understanding of
how the intervention was taken up and delivered.
HCP level evaluation
In order to capture the complexity of how the intervention
is received, delivered and managed by members of the
primary healthcare team, a range of methods will be
used. These methods include semi-structured face-to-
face interviews with HCPs, structured observations of
consultations, video-recorded simulated consultations,
and secondary data collection (for example, minutes of
meetings).
GP and practice nurse interviews and focus group
As part of the last training session, all GPs and practice
nurses will be invited to participate in a focus group, to
ascertain whether, and if so how, their views of OA treat-
ment have changed since the training, and to explore what
this means for their clinical practice. GPs and nurses from
the intervention practices will also be invited to participate
in individual telephone or face-to-face interviews after
completion of the intervention. All interviews will be
digitally-recorded and fully transcribed and conducted
six to nine months following randomisation.
Practice nurse observations
Observations of MOAC 2 consultations will be under-
taken to gain detailed insight into the consultation itself,
the interaction between the nurse and patient, and the
actual delivery of MOAC 2 in routine practice. Audio
recordings and detailed field notes will capture data for
Table 3 Population survey outcome measures







Cost of living Find it a strain to get by from week to week/Have to be careful
with Money/Able to manage without much difficulty/Quite
comfortably off
Height Feet and inches or centimetres
Weight Stones and lbs or kilograms
Work related questions to determine occupational social class
Employment status Employed / Not working due to ill health /Retired/Unemployed
or seeking work/ Housewife/Other
Spouse/partner’s job title Free Text
Work related questions including: Current employment status; Job title (or previous job title if
retired/unemployed); Spouse’s job title (or previous job title if no
longer working or deceased)
General health
SF12 version 2 (physical and mental summary score) [40] 0 - 100
GAD7 [50] 0 - 21
EQ-5D 3 level version [52] -0.59 - 1
Physical Activity
STAR [58] Three categories: 1) Physically inactive, 2) Meets the current
recommendations of physical activity, 3) Insufficiently active
Joint Pain
Specific joint pain and problems in knee/hip/hand/foot over past year Yes/No
Pain intensity in the knee/hip/hand/foot over past month 0-10
Managing Joint Problems over the last 12 months
Consultation with practice nurse (single question) Yes/No
Consultation with GP (single question) Yes/No
Medication/Treatment use (adapted for joint problems from Jinks et al
[55])
Simple count of strategies used
GP = General Practitioner; GAD 7 = Generalized Anxiety Disorder 7; EQ5D = Quality of Life; SF12 = Short Form 12; STAR = Short Telephone Activity Rating.
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to be compared.
Video-recorded simulated patient consultations
To evaluate OA consultation behaviour, the GPs in
the intervention practices will be invited to undertake
video-recorded consultations with simulated patients.
The simulated patient will take on the role of one with
chronic joint problems, and the GP will be asked to
conduct a consultation in which the problems are assessed
and a management plan agreed upon. Video-recorded
consultations will be undertaken (i) before the training
(video 1), (ii) during training (video 2), (iii) one month
after training (video 3), and (iv) six months after thetraining (video 4). Two video-recorded consultations
(videos 1 and 2) will be used as part of the training to enable
GPs to reflect on their consultation behaviours and video-
recorded consultations. Videos 1, 3 and 4 will be used to
evaluate change of behaviour after training. Video-recorded
consultations will be assessed by four independent and
blinded (to the time-point of the video-recording) raters,
using a pre-defined rating tool.
Participant level evaluation
Patient interviews
These interviews will be carried out within the four inter-
vention practices. In-depth semi-structured interviews
will be undertaken to explore patients’ experiences of
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whether the advice and support offered is relevant to pa-
tients, whether they have implemented any of the recom-
mendations, and how this has affected their perception of
OA and its management.
For MOAC 1, individual in-depth interviews will be car-
ried out in order to ascertain people’s personal experiences
and perspectives of their OA and the consultation. For
MOAC 2, dependent on patient preference, either individ-
ual or group interviews will be held - bringing together
three or four participants per group. The main reason for
choosing the group interview is to avoid people feeling
that they are being ‘checked up on’ with regards to imple-
menting the advice and support offered in MOAC 2. The
discussion within a group setting allows for the focus
to be on the relevance and adoption of the intervention
rather than on individuals.
The sampling frame for this study will be the MOSAICS
consultation questionnaire described previously. In order to
explore a range of accounts and behaviours, purposive sam-
pling is required. Further variation will be achieved by
selecting patients according to type of pain, age and gender.
All interviews will be digitally-recorded and fully transcribed.
Two groups of patients will be purposively sampled:
1. Patients who have attended MOAC 1 will be
interviewed soon after they have consulted their GP
for their joint problem. An interview guide will
provide a flexible framework for questioning, asking,
for example; how do you feel the consultation went?
Have you done anything differently? What
information was given by the GP, and was it relevant/
appropriate? How did you feel about being referred to
a nurse? Approximately 15 people will be interviewed
about their experiences of receiving MOAC 1.
2. Patients who have attended MOAC 2 will, dependent
upon patient preference, either be interviewed
individually or in small groups after completing up to
four consultations with the nurse and returning their
three-month consultation questionnaire. An interview
guide will also be used and will focus questions
around the expectations of the nurse consultation and
what happened during the consultation, how the
guidebook was used and how they felt about it, and
overall what worked and what didn’t. Approximately
15 people will be interviewed about their experience
of receiving MOAC 2. These 15 people may not be
the same as those interviewed about MOAC 1.
Evaluation of the training
Training evaluation questionnaires
Before training, to explore drivers for participation in the
study, all GPs and practice nurses in participating practices
will be invited to answer two open-ended questions thatwill focus on (i) their reasons for participating in the study
and (ii) the perceived benefits (for clinical practice, for
the primary care organisation, for their own role etc.). A
baseline questionnaire assessment of knowledge about
and beliefs and attitudes to OA and its management in
primary care, will also be conducted. We will ask the
GPs and practice nurses in the intervention practices
who have received training to complete two further ques-
tionnaires (one month and six months post-training) to
determine any change in knowledge, beliefs and atti-
tudes following the training.
All GPs and practices nurses from the control practices
will have the opportunity to attend the training at the end
of the study. They will also be asked to complete the same
evaluation questionnaire as the intervention practice staff
at baseline (pre-training) and one month after the training
(post-training).
Health economics evaluation
The economic evaluation will provide a preliminary analysis
of the cost effectiveness (cost-utility) of the template and
MOAC intervention compared with template alone, over a
12-month period.
Objectives: Study component 4
4a.To determine whether the training changes health
care professionals' behaviour.
4b.To explore change in recording in medical records,
and the uptake of core treatments for OA
recommended by NICE in all participants consulting
with joint pain (hip, knee, hand, foot) and the
subgroup coded as OA by the general practitioner,
following the MOAC intervention.
4c.To explore the cost-effectiveness of the template
and MOAC intervention compared with the
template alone.
4d.To explore patient experiences of their consultation
for joint pain and whether the new intervention
(MOAC) is acceptable and feasible in primary care
(qualitative work).
4e.To examine and evaluate the way in which a new
consultation for OA can be embedded in routine
clinical practice in primary care (implementation).
Analysis
Analysis of the cluster RCT
Baseline characteristics will be compared between treat-
ment arms and presented at the level of: (i) GP-Practice
clusters, and (ii) Patient characteristics.
Baseline data for GP-Practice characteristics will include
data on the stratification variables for randomisation – i.e.,
practice list size and the number of GP practitioners,
median index level of deprivation for the Practice, mean
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data for patients will include data pertaining to participants’
demographic characteristics, joint problem, management of
their joint problem, general health and quality of life.
Balance of baseline characteristics is particularly im-
portant to establish for cluster trials given the higher
level unit of randomisation and thus the potential for bias
in the selection and recruitment uptake of patients. No
formal statistical testing will be carried out for differences
in baseline characteristics except for the GPAQ communi-
cation sub scale [49], as this is measure of the uptake of
the model OA consultation by GPs.
Descriptive statistics on mean scores for numerical
outcomes and frequency counts and percentages for cat-
egorical data will be presented for outcome measures from
the consultation questionnaire, stratified by study group
(intervention or control). A Linear Mixed Model will be
used to analyse primary outcome data (SF-12 PCS). Statis-
tical testing of clinical and process outcomes between
study groups will be performed using regression methods
(adjusting for age, gender, baseline SF12-PCS and corre-
sponding baseline value, of the outcome being measured,
as covariates at the individual-patient level and practice
size as a covariate at the practice level). A 3-level mixed-
model (linear- or generalised- as appropriate to numerical
and categorical outcome data, respectively) will be fitted
to test for the effect of the MOAC intervention from base-
line across follow-up, taking into account clustering by
practice (level 3) and patient (level 2) and repeat follow-up
measures (level 1). P-values and 95% Confidence Intervals
will be provided with estimates of effect size in the ana-
lysis of follow up data. The mixed model assumes that
missing data is at least missing at random (MAR). We will
examine effect estimates in relation to the indicated
clinical marker of 0.3 of an effect size.
Complier Average Causal Effect Analysis (CACE)
A CACE analysis will be performed to provide an unbiased
estimate of treatment effect for patients treated as per proto-
col specification (treatment administered as per protocol in
the intervention arm is based on participants having seen
the practice nurse MOAC 2 in the intervention practices).
Key secondary outcomes will be analysed including
the Arthritis Self-Efficacy pain subscale [41] and the
OMERACT/OARSI responder criteria [42], which com-
bines measures of pain intensity (0 to 10 NRS) and function
(subscale of the WOMAC) with global assessment of change
to determine if participants are ‘responders’ to treatment.
Sub group analyses will be performed on the primary
outcome (SF-12 PCS) as well as Arthritis Self-Efficacy
pain sub-scale according to the following:
1. Age group (45 to 64 vs 65 and above);
2. Sex (male vs female);3. Baseline SF12 – physical component score (cut off
at median score);
4. Multi-site pain (less than 2 vs ≥2).
An interaction term (product of the subgroup variable
and study group) will be included as an additional term
in the regression models to evaluate the subgroup effect.
Sensitivity analyses will be conducted (this will be carried
out on primary outcome [SF-12 PCS]), details of which can
be found in Additional file 5.
Analysis of medical record data
We will split the medical records into three time periods:
the 12 months before the template installation, the 6 months
after installation but prior to randomisation, and the
12 months after start of the intervention. Eligible pa-
tients with OA or joint pain consultations in each time
period (aged 45 years and over) will be identified. To
assess the effect of the template, we will determine
changes in routine recording of OA management pre- and
post-template installation but prior to randomisation.
This will include assessment of prescribing behaviours
(paracetamol, topical NSAIDs, opioid, oral NSAIDs with
or without a PPI, weight loss agents), investigation
(use of relevant X-rays), and referral to selected specialities
including exercise referral or physiotherapy, occupational
therapy, weight loss programmes, orthopaedics, pain
management, and rheumatology. We will determine
the level of use of the template and the proportion
of patients who have evidence of achievement of each
Quality Indicator as recorded in the template in the first
six months after installation. We will assess socio-
demographic and clinical factors associated with achieve-
ment. Differences between the two clusters (template v.
template plus intervention) on practice level outcomes
will be assessed for the 12 months after the start of the
intervention. The analysis will compare (i) between clus-
ters on each of the Quality Indicator outcome measures
adjusting for baseline achievement, and (ii) within clusters
on change on each of the Quality Indicators from the six
months pre-randomisation using multilevel modelling to
adjust for clustering of patients within practices.
Analysis of HCP behaviour
General characteristics and baseline views of all GPs and
nurses involved in the study will be determined. We will
evaluate whether the knowledge, attitudes and beliefs,
and reported practice of GPs and nurses from the inter-
vention practices are (a) similar to the GPs and nurses
from the control practices and (b) change as a result of
the study training programme and involvement with OA
patients over the time course of the study.
The video-recorded simulated patient consultations
will be rated for the presence or absence of a number
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the patient’s ideas or concerns about what the patient
thinks is the matter, or did the GP tell the patient that the
problem is due to OA? The overall rating for each GP for
each consultation (the number of items rated as present)
and the overall rating for each item at each time point
(the number of GPs rated as having demonstrated that item)
will be determined. The first value is a measure of the com-
petency of a GP in delivering the model OA consultation
(GP competency), and the second is a measure of the
competency of all the GPs in delivering one element of
the model OA consultation (item competency).
The following analyses will be undertaken:
1. The number of GPs who have increased GP
competency at one month and six months post training.
2. The change in mean GP competency at one month
and six months post training.
3. The change in item competency at one month and
six months post training.Analysis of qualitative data
Data will be entered into NVIVO 9 software to aid ana-
lysis. The constant comparative method [50] will be
the primary analytical tool, but supplemented where
appropriate by narrative analysis. The use of different
data sources and methods allows for triangulation, and
the development of the coding scheme. The qualitative
team will carry out joint data analysis and interpretation
of the Normalisation Process Theory (NPT) in relation
to the data collected. The NPT will form the theoretical
framework to order emerging themes and concepts
across the intervention practices studied. The model fo-
cuses on the work that is required to get a new interven-
tion integrated and workable. The key elements are: (i)
the examination of how people as individuals and as a
group make certain practices a reality; (2) what mecha-
nisms promote or inhibit new practices; (3) the way
in which practices are (re)produced by continuous
investment by key HCPs so that it becomes part of
clinical routines. By using the NPT, the new supported
self-management strategy (the MOAC intervention and
guidebook) will be studied in its totality, so that the
findings can be more robust in terms of answering the
question: does the new intervention work, under what
circumstance, for whom and why?
Data analysis will take place in several stages. All in-
terviews will then be coded, and coding schemes will
be revised according to ongoing data analysis. Coded
data will then be compared and emerging themes dis-
cussed. The quantitative findings will be embedded
within the reporting of the analysis of the key quantita-
tive results of the study.Health economics analysis
The full Health Economics analysis plan is reported in
Additional file 6.
Discussion
Despite the publication of National and International
treatment recommendations, evidence suggests that there
is a gap between the recommendations and what patients
actually receive in the UK [11]. The NICE guidance (2008)
highlights the possible therapeutic gains of positive self-
management in primary care; however, there is as yet no
evidence regarding the feasibility of implementing NICE
core OA recommendations in primary care and the effect
of this package on the course and impact of the condition
[13]. To our knowledge, the MOSAICS study is the first to
develop and evaluate a system for delivering these core
messages in UK primary care.
Complex interventions are frequently employed in the
NHS. Trials of complex interventions are of increasing
importance because of the drive to provide the most cost
effective healthcare; however, there are issues in describing,
developing, documenting and reproducing complex in-
terventions [23]. While such trials can pose a considerable
challenge for researchers, approaches that incorporate
both qualitative and quantitative evidence should lead
to improved study design, implementation, evaluation
and generalisability of results.
The MOSAICS study is a complex intervention and
will use a cluster RCT design to test a novel intervention
designed to increase the uptake of the core NICE OA
guidelines. The primary aim is to evaluate a new model
of supported self-management for OA, and evaluate the
impact of this on practice level and HCP outcomes and in
patients consulting with joint pain. Secondary aims are
to: develop a training package for GPs and practice nurses;
test the feasibility of recording the management of OA in
consultations using ‘quality markers’ collected via a new
consultation template; and describe the uptake of core
NICE OA recommendations.
In line with the recommendations of the Medical Re-
search Council (MRC) [51], this study includes a process
evaluation component, which aims to explain any differ-
ences between what is expected and what actually hap-
pens in practice; and a health economic evaluation
component, which will make the results of the evalu-
ation more valuable to decision-makers.
Trial monitoring
The Research Centre’s independent Data Monitoring
Committee (DMC) will monitor the trial, and reports will
be written in line with Arthritis Research UK recommenda-
tions (www.arthritisresearchuk.org). The trial will also be
monitored by an independent trial steering committee
(TSC) annually. This committee is made up of individuals
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rheumatology, biostatistics, nursing, community-based
research, and health economics. The committee also in-
cludes a representative from Arthritis Care and an OA re-
search user group. Both committees will be notified of any
serious adverse events that may occur during the trial.
Patient and public involvement (PPI)
The Arthritis Research UK Primary Care Centre at Keele is
committed to taking an explicit and systematic approach
to involving patients and the public in research. For the
MOSAICs study, the Research Users’ group will work
in collaboration with researchers on a wide range of tasks.
These tasks will focus on aspects of research design, man-
agement and dissemination. Some examples of involvement
include: development and design of the OA guidebook,
advice on the content of the population survey, develop-
ment of Quality Indicators for general practice consulta-
tions, involvement in developing training for HCPs and
Steering Committee Membership.
Trial sponsor: Keele University
The sponsor will have no role in the design and analysis of
the data.
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